MedPath

The Evaluation in usefulness of Guiding Marker SystemTM and magnetic probe, for detecting and resecting of non-palpable lesions of the breast

Not Applicable
Conditions
Breast Cancer
Registration Number
JPRN-jRCTs032180422
Lead Sponsor
Takeo Hiroyuki
Brief Summary

This feasibility study demonstrated that the magnetic guiding localization is useful for localization of non-palpable breast lesion. The identification rate of nonpalpable lesion was high, and the rate of positive surgical margin was low.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
41
Inclusion Criteria

1.Non-palpable breast cancer or non-palpable lesion suspected breast cancer which is planed surgical procedure.
2.Over 20 years old when its consented
3.Written informed consent

Exclusion Criteria

1.Metal allergy
2.Patient who had breast implant insertion surgery
3.Breast cancer patient in pregnancy period or lactation period
4.Male breast cancer
5.Inflammatory breast cancer
6.Patient who is assessed not applicable by physicians

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Complete resection of guiding marker
Secondary Outcome Measures
NameTimeMethod
Positive rate of the surgical margin<br>Re-operation / boost radiation within 3 months after breast conserving surgery <br>Safety
© Copyright 2025. All Rights Reserved by MedPath